These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 13945019)

  • 21. Effect of administration of phenindione on blood levels of prothrombin, autoprothrombin I and autoprothrombin II.
    JOHNSON SA; CALDWELL MJ; PRIEST EM
    J Appl Physiol; 1958 Nov; 13(3):411-6. PubMed ID: 13587424
    [No Abstract]   [Full Text] [Related]  

  • 22. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 23. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 24. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 25. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison between micro-modifications of prothrombin-proconvertin determinations and of the prothrombin time method.
    DYGGVE H
    Scand J Clin Lab Invest; 1958; 10(1):1-4. PubMed ID: 13555683
    [No Abstract]   [Full Text] [Related]  

  • 27. [IMPORTANCE OF THE THROMBOTEST. II. A COMPARATIVE STUDY OF THE THROMBOTEST, THROMBOPLASTIN TIME AND PARTIAL THROMBOPLASTIN TIME].
    FREDERIKS PW
    Ned Tijdschr Geneeskd; 1964 Jan; 108():156-61. PubMed ID: 14135805
    [No Abstract]   [Full Text] [Related]  

  • 28. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 29. EFFECT OF SUDDEN WITHDRAWAL OF LONG-TERM ANTICOAGULANT THERAPY ON THE HEPARIN RESISTANCE AND PLASMA FIBRINOGEN LEVEL.
    COTTON RC; WADE EG
    Clin Sci; 1964 Apr; 26():337-43. PubMed ID: 14162427
    [No Abstract]   [Full Text] [Related]  

  • 30. Deficiency of prothrombin and proconvertin after therapy with propylthiouracil.
    KOLARS CP; GONYEA LM
    J Am Med Assoc; 1959 Dec; 171():2315-8. PubMed ID: 14410667
    [No Abstract]   [Full Text] [Related]  

  • 31. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of the prothrombin-proconvertin determinations (Owren-Aas) with prothrombin-index obtained with the Larsen-Plum prothrombin time method.
    LUND E; GEILL T; SØNDERGAARD E; DAM H
    Scand J Clin Lab Invest; 1955; 7(1):69-74. PubMed ID: 14396286
    [No Abstract]   [Full Text] [Related]  

  • 33. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].
    FORELL MM; KOLLER F
    Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403
    [No Abstract]   [Full Text] [Related]  

  • 34. [THROMBOTEST IN ANTICOAGULANT CONTROL: A COMPARATIVE STUDY WITH QUICK'S ONE-STAGE PROTHROMBIN DETERMINATION].
    RETIEF FP
    S Afr Med J; 1964 Jul; 38():534-8. PubMed ID: 14176704
    [No Abstract]   [Full Text] [Related]  

  • 35. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 36. EFFECT OF ORAL ANTICOAGULANTS ON FACTORS VII, IX, X, AND II.
    KAZMIER F; SPITTELL JA; THOMPSON JJ; OWEN CA
    Arch Intern Med; 1965 Jun; 115():667-73. PubMed ID: 14299436
    [No Abstract]   [Full Text] [Related]  

  • 37. CONTROL OF ANTICOAGULANT THERAPY BY THROMBOTEST METHOD.
    KEYSER JW
    Br Med J; 1963 Dec; 2(5371):1514-6. PubMed ID: 14063080
    [No Abstract]   [Full Text] [Related]  

  • 38. [Comparative influence of coumadine and pindione on the prothrombin levels and coagulability index].
    BUREAU DU COLOMBIER H
    Angeiologie; 1962; 14():25-7. PubMed ID: 13874764
    [No Abstract]   [Full Text] [Related]  

  • 39. CONTROL OF ANTICOAGULANT THERAPY: POSTAL COMPARISON BETWEEN FIVE CENTRES.
    STAFFORD JL
    J Clin Pathol; 1964 Sep; 17(5):531-5. PubMed ID: 14207787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATROMID AND ANTICOAGULANT THERAPY.
    WILLIAMS GE; MEYNELL MJ; GADDIE R
    J Atheroscler Res; 1963; 3():658-70. PubMed ID: 14100910
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.